Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
13.62
-1.20 (-8.07%)
At close: Nov 12, 2026, 4:00 PM EST
13.63
+0.01 (0.07%)
Pre-market: Nov 13, 2026, 4:02 AM EST
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $1.94 billion as of November 12, 2026. It is the 6,683rd most valuable company in the world and the 1,771st biggest in the United States. Its market cap has increased by 31.74% in one year.
Market Cap
1.94B
Enterprise Value
1.64B
1-Year Change
31.74%
Global Rank
Country Rank
#1,771 United States
Category
ChartMarket Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $1.94B, an increase of 2,184.11%. That is a compound annual growth rate of 51.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 1.94B | 20.92% |
| Dec 31, 2025 | 1.61B | 336.04% |
| Dec 31, 2024 | 368.19M | 330.28% |
| Dec 29, 2023 | 85.57M | -26.01% |
| Dec 30, 2022 | 115.65M | 472.04% |
| Dec 31, 2021 | 20.22M | -54.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zymeworks | 2.24B |
| Biohaven | 2.22B |
| Immunome | 2.19B |
| Aurinia Pharmaceuticals | 2.18B |
| Recursion Pharmaceuticals | 2.18B |
| Vera Therapeutics | 2.17B |
| Replimune Group | 2.17B |
| First Tracks Biotherapeutics | 2.15B |